Product Information
POTASSIUM CL 20 MEQ PACKET is a generic product labeled by Advagen Pharma Ltd., priced at $0.6242 per EA under NDC 72888002443. Its NADAC has been published 183 times since Apr 5, 2023.
FDA first approved this application on Mar 24, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
1.5 g/1.58g
Manufacturer
Advagen Pharma Ltd.NDC
72888002443
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214108FDA Approved
3/24/2022
TE Code
AA
On Market Since
3/24/2022
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL 20 MEQ PACKET has been published 183 times since Apr 5, 2023, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6242 per EA |
|---|---|
| All-time high | $2.8729 (Jul 12, 2023) |
| All-time low | $0.5943 (Aug 19, 2026) |
| 52-week high | $0.9641 |
| 52-week low | $0.5943 |
| Median price | $1.0515 |
| Average price | $1.2052 |
| Largest weekly change | -47.9% (Jul 19, 2023) |
| Weeks tracked | 183 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL 20 MEQ PACKET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL 20 MEQ PACKET, manufactured by Advagen Pharma Ltd., is $0.6242 per EA (NDC 72888002443), effective Sep 30, 2026.
How has the price of POTASSIUM CL 20 MEQ PACKET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL 20 MEQ PACKET has declined 77.3%. It has been tracked across 183 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL 20 MEQ PACKET?
Since Apr 5, 2023, the NADAC for POTASSIUM CL 20 MEQ PACKET has ranged from a low of $0.5943 (Aug 19, 2026) to a high of $2.8729 (Jul 12, 2023), with a median of $1.0515 per EA.
Are there cheaper alternatives to POTASSIUM CL 20 MEQ PACKET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL 20 MEQ PACKET, is $0.5943 per EA — about 5% below POTASSIUM CL 20 MEQ PACKET.
Who manufactures POTASSIUM CL 20 MEQ PACKET?
POTASSIUM CL 20 MEQ PACKET (NDC 72888002443) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.